SCHEMBL1180140

SCHEMBL1180140

Oc1[c]nccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL405529 0.74
SCHEMBL269899 0.74
SCHEMBL1180684 0.70
SCHEMBL5480949 0.70
SCHEMBL2066991 0.70
SCHEMBL3432939 0.70
SCHEMBL558368 0.70
SCHEMBL1180970 0.70
SCHEMBL1854469 0.70
SCHEMBL2066577 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130045993-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES AND THEIR USE Piramal Enterprises Limited (IN) 2013-02-21 US disclosed
US-8304449-B2 Inhibitors of cyclin dependent kinases and their use PIRAMAL HEALTHCARE LIMITED (IN) 2012-11-06 US disclosed
US-20110136873-A1 Inhibitors of Cyclin Dependent Kinases and Their Use PIRAMAL LIFE SCIENCES LTD. (IN) 2011-06-09 US disclosed
US-7915301-B2 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one Piramal Life Science Limited (IN) 2011-03-29 US disclosed
US-7884127-B2 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one; acidification Pirimal Life Sciences Ltd. (IN) 2011-02-08 US disclosed
US-20080108690-A1 INHIBITORS OF CYCLIN DEPENDENT KINASES AND THEIR USE NICHOLAS PIRAMAL INDIA LIMITED (IN) 2008-05-08 US disclosed
US-7271193-B2 Inhibitors of cyclin-dependent kinases and their use NICHOLAS PIRAMAL INDIA, LTD. (IN) 2007-09-18 US disclosed
US-20070208021-A1 Phenoxyacetic Acid Derivatives and Drug Comprising The Same DAIICHI PHARMACEUTICAL CO., LTD. 2007-09-06 US disclosed
US-20070015802-A1 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one; acidification NICHOLAS PIRAMAL INDIA LIMITED (IN) 2007-01-18 US disclosed
EP-1731513-A1 PHENOXYACETIC ACID DERIVATIVE AND MEDICINE CONTAINING THE SAME DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-13 EP disclosed
EP-1556375-A2 FLAVONE DERIVATIVES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES Nicholas Piramal India Limited (IN) 2005-07-27 EP disclosed
US-20040106581-A1 Inhibitors of cyclin-dependent kinases and their use NICHOLAS PIRAMAL INDIA LIMITED (IN) 2004-06-03 US disclosed
WO-2004004632-A2 FLAVONE DERIVATIVES AS INHIBITORS OF CYCLIN-DEPENDENT KINASES NICHOLAS PIRAMAL INDIA LIMITED (IN) 2004-01-15 WO disclosed
EP-0215739-A1 Synthesis of beta-lactam compounds CIBA-GEIGY AG (CH) 1987-03-25 EP disclosed
EP-0201459-A1 Acylaminomethyl-penem compounds, their preparation and pharmaceutical formulations containing them CIBA-GEIGY AG (CH) 1986-11-12 EP disclosed
EP-0112283-A1 Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use CIBA-GEIGY AG (CH) 1984-06-27 EP disclosed
EP-0109362-A1 Hetereocyclic compounds, process for their preparation, pharmaceutical compositions containing them and their use CIBA-GEIGY AG (CH) 1984-05-23 EP disclosed
EP-0009008-A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1980-03-19 EP disclosed